Actionable Locoregional Relapses after Therapy of Localized Esophageal Cancer: Insights from a Large Cohort
暂无分享,去创建一个
J. Ajani | S. Swisher | R. Komaki | W. Hofstetter | Jeffrey H. Lee | M. Bhutani | D. Maru | D. Rice | H. Skinner | Xuemei Wang | B. Weston | M. Blum | H. Shiozaki | W. Qiao | J. Rogers | E. Elimova | R. Wadhwa | Yusuke Shimodaira | K. Sudo | N. Charalampakis | Venkatram Planjery | D. Rice
[1] AJCC Cancer Staging Manual 7th Edition , 2020, Definitions.
[2] D. Schlundt,et al. Life Experience of Patients With Unilateral Vocal Fold Paralysis , 2018, JAMA otolaryngology-- head & neck surgery.
[3] G. Torzilli,et al. Improving the Safety of ALPPS Procedure: The Optimal Compromise Between Dropout and Mortality Risk. Comment on Schadde E et al Prediction of Mortality After ALPPS Stage-1: An Analysis of 320 Patients From the International ALPPS Registry. Ann Surg. 2015;262: 780-786. , 2017, Annals of surgery.
[4] Qiaojia Huang,et al. Single Nucleotide Polymorphism of the Enhancer of Zeste Homolog 2 Gene rs2072408 is Associated with Lymph Node Metastasis and Depth of Primary Tumor Invasion in Gastric Cancer. , 2016, Clinical laboratory.
[5] C. Mariette,et al. Reply to Letter: "The Role of Surgery for Patients With a Complete Clinical Response After Chemoradiation for Esophageal Cancer". , 2015, Annals of surgery.
[6] Adam P Dicker,et al. American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] S. Pita-Fernández,et al. Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] J. Ajani,et al. Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] C. Willett,et al. Patterns of recurrence after trimodality therapy for esophageal cancer , 2014, Cancer.
[10] D. Richel,et al. Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] J. Ajani,et al. Locoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategies. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] J. Ajani,et al. Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma patients who achieve a clinical complete response after chemoradiation. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[13] G. Whalen,et al. Rational follow-up after curative cancer resection. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] E W Steyerberg,et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. , 2012, The New England journal of medicine.
[15] J. Ajani,et al. Failure patterns in patients with esophageal cancer treated with definitive chemoradiation , 2012, Cancer.
[16] B. Trock,et al. The natural history of metastatic progression in men with prostate‐specific antigen recurrence after radical prostatectomy: long‐term follow‐up , 2012, BJU international.
[17] Quan P. Ly,et al. Esophageal and esophagogastric junction cancers. , 2011, Journal of the National Comprehensive Cancer Network : JNCCN.
[18] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[19] Jian-ping Wang,et al. The role of postoperative colonoscopic surveillance after radical surgery for colorectal cancer: a prospective, randomized clinical study. , 2009, Gastrointestinal endoscopy.
[20] D. Jeffe,et al. Surveillance mammography and the risk of death among elderly breast cancer patients , 2008, Breast Cancer Research and Treatment.
[21] W. Chow,et al. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. , 2008, Journal of the National Cancer Institute.
[22] T. Lash,et al. Mammography surveillance and mortality in older breast cancer survivors. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] A. Lacy,et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] T. Lash,et al. Reduced Mortality Rate Associated with Annual Mammograms after Breast Cancer Therapy , 2006, The breast journal.
[25] Alan W Partin,et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. , 2005, JAMA.
[26] H. Welch,et al. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. , 2005, Journal of the National Cancer Institute.
[27] M. Blaser,et al. Population attributable risks of esophageal and gastric cancers. , 2003, Journal of the National Cancer Institute.
[28] H. Schmoll,et al. F.L. Greene, D.L. Page, I.D. Fleming et al. (eds). AJCC Cancer Staging Manual, 6th edition , 2003 .
[29] J. Cooper,et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. , 1999, JAMA.
[30] R. Costi,et al. Role of follow-up in management of local recurrences of colorectal cancer , 1998, Diseases of the colon and rectum.
[31] M. Indelli,et al. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators. , 1994, JAMA.
[32] C. Mariette,et al. The impact of preoperative radiochemotherapy on survival in advanced esophagogastric junction signet ring cell adenocarcinoma. , 2014, The Annals of thoracic surgery.
[33] J. Ajani,et al. Factors Associated with Local–Regional Failure After Definitive Chemoradiation for Locally Advanced Esophageal Cancer , 2013, Annals of Surgical Oncology.
[34] S. Law. Chemoradiotherapy - panacea for esophageal cancer? Commentary for 'Chemoradiotherapy of locally advanced esophageal cancer. Long-term follow-up of a prospective randomized trial (RTOG 85-01)' , 1999 .
[35] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.